Clinical efficacy and safety of guselkumab maintenance therapy in patients with moderately to severely active Crohn's disease: Week 48 analyses from the Phase 2 GALAXI-1 study

被引：0

作者：

Danese, S. ^{[1
,2
]}

Panaccione, R.

Rubin, D. T. ^{[3
,6
]}

Sands, B. E. ^{[7
]}

Reinisch, W. ^{[11
]}

D'Haens, G. ^{[12
]}

Panes, J. ^{[13
]}

Gonzalez, S. ^{[8
]}

Weisel, K. ^{[8
]}

Sahoo, A. ^{[8
]}

Frustaci, M. E. ^{[8
]}

Yang, Z. ^{[8
]}

Sandborn, W. J. ^{[9
]}

Afzali, A. ^{[10
]}

Hisamatsu, T. ^{[14
]}

Andrews, J. M. ^{[15
,16
]}

Feagan, B. G. ^{[4
,5
]}

机构：

[1] IRCCS Osped San Raffaele, Gastroenterol & Endoscopy, Milan, Italy

[2] Univ Vita Salute San Raffaele, Milan, Italy

[3] Univ Calgary, Inflammatory Bowel Dis Grp, Calgary, AB, Canada

[4] Western Univ, London, ON, Canada

[5] Alimentiv Inc, Robarts Clin Trials Inc, London, ON, Canada

[6] Univ Chicago, Med Inflammatory Bowel Dis Ctr, Chicago, IL USA

[7] Icahn Sch Med Mt Sinai, Dr Henry Janowitz Div Gastroenterol, New York, NY 10029 USA

[8] Immunology Janssen Res & Dev, Spring House, PA USA

[9] Univ Calif San Diego, Div Gastroenterol, La Jolla, CA USA

[10] Ohio State Univ, Wexner Med Ctr, Columbus, OH USA

[11] Med Univ Vienna, Div Gastroenterol & Hepatol, Vienna, Austria

[12] Univ Amsterdam, Dept Gastroenterol, Med Ctr, Amsterdam, Netherlands

[13] Hosp Clin Barcelona, IDIBAPS, CIBERehd, Barcelona, Spain

[14] Kyorin Univ, Dept Gastroenterol & Hepatol, Tokyo, Japan

[15] Royal Adelaide Hosp, Dept Gastroenterol & Hepatol, Adelaide, SA, Australia

[16] Univ Adelaide, Adelaide, SA, Australia

来源：

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

引用

页码：127 / 129

页数：3